Table 2.
Association of IL-10 genotypes with tumor HPV16 status among patients with SCCOP
IL-10 genotype | HPV16+ patients, N = 230 |
HPV16− patients, N = 79 |
P | Adjusted OR and 95% CI | ||
---|---|---|---|---|---|---|
n | % | n | % | |||
IL-10 rs1800871 | 0.001 | |||||
CCa | 113 | 49.1 | 56 | 70.9 | 1.0 | |
CT + TT | 117 | 50.9 | 23 | 29.1 | 2.6 (1.5–4.5) | |
IL-10 rs1800872 | 0.001 | |||||
CCa | 109 | 47.4 | 54 | 68.4 | 1.0 | |
CA + AA | 121 | 52.6 | 25 | 31.7 | 2.4 (1.4–4.2) | |
IL-10 rs1800896 | 0.483 | |||||
AAa | 83 | 36.1 | 32 | 40.5 | 1.0 | |
GA + GG | 147 | 63.9 | 47 | 59.5 | 1.0 (0.6–1.8) |
P values for χ2 test for genotype distribution. OR and 95% CI were adjusted for age, sex, ethnicity, and tobacco smoking and alcohol consumption status in a logistic regression model.
Reference group.